Auto Draft

Auna S.A. (NYSE:AUNA) is one of the best medical care facilities stocks to buy according to analysts. Analysts’ average target implies about 32.6% upside, although the stock comes with a more mixed signal than several others on the list. The freshest analyst-specific update was on May 26, when JPMorgan maintained a Hold rating and lowered its price target to $5 from $6. That is not bullish by itself, and it keeps the stock from looking like a simple consensus-favorite story.

Why Auna’s (AUNA) Analyst Upside Depends on Latin American Healthcare Platform Execution

However, the broader analyst set compiled by S&P Global still showed a Buy consensus and an average target of $6.99, with seven analysts covering the company. Fitch also affirmed Auna’s B+ rating on May 22, while flagging leverage levels that remain material. The measured takeaway is that analysts still see upside on average, but the case depends on execution across a vertically integrated Latin American healthcare platform, including hospitals, outpatient centers, and health plans, rather than clean U.S. hospital exposure.

Auna S.A. (NYSE:AUNA) operates hospitals and clinics in Mexico, Peru, and Colombia, and also provides prepaid healthcare, dental and vision insurance, oncology plans, and medicines.

While we acknowledge the risk and potential of AUNA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AUNA and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1